Valproate-induced thrombocytopenia

Background. Valproic acid is widely prescribed as an antiepileptic drug and mood stabilizer. Fatigue, tremor, sedation, hepatotoxicity, weight gain, hair loss and thrombocytopenia have been reported as side effects. Drug-induced thrombocytopenia occurs as the valproic acid dosage exceeds 1000 mg/day...

Full description

Bibliographic Details
Published in:	Лечащий Врач
Main Authors:	N. V. Izmozherova, A. A. Popov, I. P. Antropova, L. I. Kadnikov, D. A. Kruzhevnikova, O. A. Makarova
Format:	Article
Language:	Russian
Published:	Open Systems Publication 2024-04-01
Subjects:	platelets thrombocytopenia valproic acid hemostasis
Online Access:	https://journal.lvrach.ru/jour/article/view/1219

Similar Items

Valproic Acid and Thrombocytopenia
by: J Gordon Millichap
Published: (1996-08-01)

Unveiling Thrombocytopenia Trends In Pediatric Epilepsy: The Valproate Connection
by: Kiran Nayab, et al.
Published: (2025-01-01)

Liver transplantation of a patient with extreme thrombocytopenia - A case report -
by: Yena Oh, et al.
Published: (2021-07-01)

Nomogram for the prediction of valproic acid induced platelet decline: a nested case–control study
by: Gang Cheng, et al.
Published: (2025-03-01)

Valproate-Induced Cytopenias
by: J Gordon Millichap
Published: (1990-10-01)

Mechanisms of valproate-induced teratogenesis
by: D. V. Dmitrenko, et al.
Published: (2017-06-01)

Valproate-Induced Thrombocytopenia
by: J Gordon Millichap
Published: (1994-06-01)

Platelet Function and Valproate
by: J Gordon Millichap
Published: (1999-03-01)

Valproate-Induced Metabolic Syndrome
by: Natalia A. Shnayder, et al.
Published: (2023-05-01)

Carnitine in Valproate-Induced Hyperammonemia
by: J Gordon Millichap
Published: (1996-06-01)

Valproate-Induced Malformations
by: J Gordon Millichap
Published: (1987-11-01)

Adenovirus vectors can infect mouse megakaryocytes – implications for vaccine-induced thrombosis/thrombocytopenia
by: Simon Collett, et al.
Published: (2025-05-01)

Valproate-Induced Encephalopathy in Three Cases
by: Fatma Polat, et al.
Published: (2010-12-01)

Valproate-Induced Encephalopathy in Three Cases
by: Fatma Polat, et al.
Published: (2010-12-01)

Risk factors for thrombocytopenia associated with intravenous valproic acid therapy in pediatric patients undergoing neurosurgical operations
by: Zhaosong Du, et al.
Published: (2025-04-01)

Valproate induced thrombocytopenia complicating acute febrile illness
by: Elizabeth K, et al.
Published: (2006-01-01)

Valproate induced hyperammonemic encephalopathy: a rare adverse effect of a common drug
by: Sanaullah Mudassir, et al.
Published: (2023-12-01)

PHARMACO-ECONOMIC EVALUATION OF THE USE OF VALPROATES IN TABLET FORMS IN EPILEPSY THERAPY
by: P. A. Balunov
Published: (2017-05-01)

Association of platelet satellitism with immune thrombocytopenia: A case report and review of literature
by: Junaid A. Wali, et al.
Published: (2024-06-01)

Subcutaneous panniculitis as complication of valproate-induced pancreatitis
by: Michel Tawk, et al.
Published: (2025-01-01)

Valproate Metabolites During Treatment of Infantile Spasms
by: J Gordon Millichap
Published: (1992-03-01)

Valproate-induced disorders of dopamine metabolism and the development of valproate-induced parkinsonism: a new perspective on prevention and diagnosis
by: N. A. Shnayder, et al.
Published: (2025-06-01)

Thrombocytopenia in Iraqi Pregnant Women.
by: Asmaa M Thanoon, et al.
Published: (2011-07-01)

Chemotherapy induced thrombocytopenia treated by four types of platelets concentrates
by: Nikolić Ljubinka I., et al.
Published: (2015-01-01)

Hepatocerebral Degeneration or Valproate Toxicity
by: J Gordon Millichap
Published: (1993-01-01)

Differences in serum concentration with valproate oral solution versus delayed-release divalproex in an adherent patient
by: Davis Erica A. K. PharmD, BCPS, BCPP
Published: (2023-06-01)

Valproate for Intractable Epilepsy
by: J Gordon Millichap
Published: (1992-03-01)

EPILEPSY AT ADULTS: GENDER COMORBIDE DISORDERS, APPLICATION OF VALPROATES
by: P. N. Vlasov
Published: (2016-06-01)

Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion
by: Jonathan S. Williams, et al.
Published: (2018-01-01)

Prevalence of Thrombocytopenia in COVID-19 Isolated Patients
by: Hossam Hassan, et al.
Published: (2022-12-01)

Effect of Resveratrol on Sodium Valproate-Induced Oxidative Stress in the Hippocampal Tissue of BALB/c Mouse Fetuses
by: Zakieh Solbi, et al.
Published: (2025-03-01)

Use of valproates in women of childbearing age and pregnant women with epilepsy
by: P. N. Vlasov
Published: (2015-03-01)

Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia
by: Bianca Clerici, et al.
Published: (2024-06-01)

Importance of platelet indices in the establishment of etiopathological categorization of thrombocytopenia in children
by: Arijit Majumdar, et al.
Published: (2021-01-01)

Immature platelet fraction related parameters in the differential diagnosis of thrombocytopenia
by: Junxun Li, et al.
Published: (2020-08-01)

Evaluation of Changes in Platelet Level and Influenced Factors in Patients with Thrombocytopenia
by: Babak Alikiaii, et al.
Published: (2018-03-01)

THROMBOCYTOPENIAS
by: S. A. Vasiliev, et al.
Published: (2016-06-01)

Viruses and thrombocytopenia
by: Reyhaneh Rasizadeh, et al.
Published: (2024-03-01)

Comparing the Effectiveness and Complications of Sodae and Sodium Valproate on Migraine
by: Mansour Rezaei, et al.
Published: (2023-10-01)

Reversible Valproate Induced Pisa Syndrome and Parkinsonism in a Neuro-Oncology Patient with Depression and Epilepsy
by: Andrea Botturi, et al.
Published: (2016-06-01)